Michael Binks is a VP of Rare Disease research at Pfizer and is a scientifically focused drug discovery and early clinical development professional.

Nicola Miller is the editor in Chief of Rare Revolution Magazine which is a voice and a platform for patients groups, industry, professionals, clinical and healthcare providers and charities.

Tim Guilliams is the CEO of Healx and is passionate about using big data and artificial intelligence to accelerate treatments for rare diseases.